These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23265900)

  • 41. Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Kawashima E; Freeman GA; Koszalka GW; Drach JC; Townsend LB
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):125-53. PubMed ID: 10772706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antiviral activity of C2 analogs of enviroxime: an exploration of the role of critical functionality.
    Victor F; Loncharich R; Tang J; Spitzer WA
    J Med Chem; 1997 Oct; 40(21):3478-83. PubMed ID: 9341923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
    Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
    Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and antiviral assays of some 2-substituted benzimidazole-N-carbamates.
    Garuti L; Roberti M; Gentilomi G
    Farmaco; 2000 Jan; 55(1):35-9. PubMed ID: 10755229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
    Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
    J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antioxidant activities of some new triheterocyclic compounds containing benzimidazole, thiophene, and 1,2,4-triazole rings.
    Menteşe E; Yılmaz F; Baltaş N; Bekircan O; Kahveci B
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):435-41. PubMed ID: 25198894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
    Hu L; Kully ML; Boykin DW; Abood N
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
    Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.
    Francesconi V; Cichero E; Schenone S; Naesens L; Tonelli M
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors.
    Buchstaller HP; Burgdorf L; Finsinger D; Stieber F; Sirrenberg C; Amendt C; Grell M; Zenke F; Krier M
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2264-9. PubMed ID: 21420298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of 1-substitutes-5(6)-nitrobenzimidazoles as potential antiviral compounds.
    Adams DR; Martul R
    Acta Cient Venez; 1990; 41(2):88-92. PubMed ID: 1966927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conversion of 3-arylazo-5-phenyl-2(3H)-furanones into other heterocycles of anticipated biological activity.
    Sayed HH; Hashem AI; Yousif NM; El-Sayed WA
    Arch Pharm (Weinheim); 2007 Jun; 340(6):315-9. PubMed ID: 17562565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterocyclic rimantadine analogues with antiviral activity.
    Zoidis G; Fytas C; Papanastasiou I; Foscolos GB; Fytas G; Padalko E; De Clercq E; Naesens L; Neyts J; Kolocouris N
    Bioorg Med Chem; 2006 May; 14(10):3341-8. PubMed ID: 16439137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Chien TC; Saluja SS; Drach JC; Townsend LB
    J Med Chem; 2004 Nov; 47(23):5743-52. PubMed ID: 15509173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A review.
    Mermer A; Keles T; Sirin Y
    Bioorg Chem; 2021 Sep; 114():105076. PubMed ID: 34157555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
    Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
    J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QSARs of some novel isosteric heterocyclics with antifungal activity.
    Yalçin I; Oren I; Temiz O; Sener EA
    Acta Biochim Pol; 2000; 47(2):481-6. PubMed ID: 11051213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability.
    Chino A; Masuda N; Amano Y; Honbou K; Mihara T; Yamazaki M; Tomishima M
    Bioorg Med Chem; 2014 Jul; 22(13):3515-26. PubMed ID: 24837154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.